InvestorsHub Logo
Followers 0
Posts 421
Boards Moderated 0
Alias Born 04/17/2018

Re: GunHawk post# 13288

Thursday, 05/17/2018 9:18:11 AM

Thursday, May 17, 2018 9:18:11 AM

Post# of 18666
OXS-3550 TriKE has been proven to superior to OXS-1550 in in vivo studies, so I don't expect OXS-1550 to pass Phase II trials, however OXS-3550 TriKE most likely will. As it has been proven to be more effective than Rituxan in killing cancer cells.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GTBP News